Splice Bio awarded with a “RETOS de Colaboración” grant
BARCELONA, January 26, 2023 – SpliceBio, a genetic medicines company on a mission to expand the universe of diseases that can be addressed with gene therapy, announced today that it has been awared a “Colaboración Público-Privada” grant from the Spanish Ministry of Science and Innovation (CPP2021-00899).